{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:48:32Z","timestamp":1761662912347},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,9]],"date-time":"2010-10-09T00:00:00Z","timestamp":1286582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1742-4690-7-83","type":"journal-article","created":{"date-parts":[[2010,10,9]],"date-time":"2010-10-09T18:13:49Z","timestamp":1286648029000},"source":"Crossref","is-referenced-by-count":14,"title":["In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy"],"prefix":"10.1186","volume":"7","author":[{"given":"Tanya Lynn","family":"Applegate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald John","family":"Birkett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen John","family":"Mcintyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel Belisario","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Michael","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,9]]},"reference":[{"issue":"Suppl 1","key":"2127_CR1","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2005.11.021","volume":"44","author":"P Yeni","year":"2006","unstructured":"Yeni P: Update on HAART in HIV. J Hepatol. 2006, 44 (Suppl 1): S100-103. 10.1016\/j.jhep.2005.11.021.","journal-title":"J Hepatol"},{"key":"2127_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature02870","volume":"431","author":"GJ Hannon","year":"2004","unstructured":"Hannon GJ, Rossi JJ: Unlocking the potential of the human genome with RNA interference. Nature. 2004, 431: 371-378. 10.1038\/nature02870.","journal-title":"Nature"},{"key":"2127_CR3","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1056\/NEJMra045004","volume":"351","author":"M Stevenson","year":"2004","unstructured":"Stevenson M: Therapeutic potential of RNA interference. N Engl J Med. 2004, 351: 1772-1777. 10.1056\/NEJMra045004.","journal-title":"N Engl J Med"},{"key":"2127_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1111444","volume":"309","author":"PD Zamore","year":"2005","unstructured":"Zamore PD, Haley B: Ribo-gnome: the big world of small RNAs. Science. 2005, 309: 1519-1524. 10.1126\/science.1111444.","journal-title":"Science"},{"key":"2127_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1742-4690-4-80","volume":"4","author":"Y Naito","year":"2007","unstructured":"Naito Y, Nohtomi K, Onogi T, Uenishi R, Ui-Tei K, Saigo K, Takebe Y: Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology. 2007, 4: 80-10.1186\/1742-4690-4-80.","journal-title":"Retrovirology"},{"key":"2127_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","volume":"14","author":"O ter Brake","year":"2006","unstructured":"ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther. 2006, 14: 883-892. 10.1016\/j.ymthe.2006.07.007.","journal-title":"Mol Ther"},{"key":"2127_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1742-4690-6-55","volume":"6","author":"GJ Mcintyre","year":"2009","unstructured":"Mcintyre GJ, Groneman JL, Yi-Hsin Y, Jaramillo A, S S, Applegate TL: 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology. 2009, 6: 55-10.1186\/1742-4690-6-55.","journal-title":"Retrovirology"},{"key":"2127_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/nar\/gki220","volume":"33","author":"EM Westerhout","year":"2005","unstructured":"Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005, 33: 796-804. 10.1093\/nar\/gki220.","journal-title":"Nucleic Acids Res"},{"key":"2127_CR9","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1128\/JVI.77.21.11531-11535.2003","volume":"77","author":"D Boden","year":"2003","unstructured":"Boden D, Pusch O, Lee F, Tucker L, Ramratnam B: Human immunodeficiency virus type 1 escape from RNA interference. Journal of Virology. 2003, 77: 11531-11535. 10.1128\/JVI.77.21.11531-11535.2003.","journal-title":"Journal of Virology"},{"key":"2127_CR10","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","volume":"78","author":"AT Das","year":"2004","unstructured":"Das AT, Brummelkamp TR, Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. Journal of Virology. 2004, 78: 2601-2605. 10.1128\/JVI.78.5.2601-2605.2004.","journal-title":"Journal of Virology"},{"key":"2127_CR11","doi-asserted-by":"publisher","first-page":"7658","DOI":"10.1128\/JVI.00078-06","volume":"80","author":"H Nishitsuji","year":"2006","unstructured":"Nishitsuji H, Ikeda T, Miyoshi H, Ohashi T, Kannagi M, Masuda T: Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration. Journal of Virology. 2006, 80: 7658-7666. 10.1128\/JVI.00078-06.","journal-title":"Journal of Virology"},{"key":"2127_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/JVI.80.2.571-577.2006","volume":"80","author":"R Sabariegos","year":"2006","unstructured":"Sabariegos R, Gimenez-Barcons M, Tapia N, Clotet B, Martinez MA: Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J Virol. 2006, 80: 571-577. 10.1128\/JVI.80.2.571-577.2006.","journal-title":"J Virol"},{"key":"2127_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bmt.1705895","volume":"41","author":"DB Kohn","year":"2008","unstructured":"Kohn DB: Gene therapy for childhood immunological diseases. Bone Marrow Transplant. 2008, 41: 199-205. 10.1038\/sj.bmt.1705895.","journal-title":"Bone Marrow Transplant"},{"key":"2127_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1517\/14712598.8.4.397","volume":"8","author":"G Santilli","year":"2008","unstructured":"Santilli G, Thornhill SI, Kinnon C, Thrasher AJ: Gene therapy of inherited immunodeficiencies. Expert Opin Biol Ther. 2008, 8: 397-407. 10.1517\/14712598.8.4.397.","journal-title":"Expert Opin Biol Ther"},{"key":"2127_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12026-008-8051-z","volume":"43","author":"EM Kang","year":"2009","unstructured":"Kang EM, Malech HL: Advances in treatment for chronic granulomatous disease. Immunol Res. 2009, 43: 77-84. 10.1007\/s12026-008-8051-z.","journal-title":"Immunol Res"},{"key":"2127_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/104303404322886101","volume":"15","author":"RG Amado","year":"2004","unstructured":"Amado RG, Mitsuyasu RT, Rosenblatt JD, Ngok FK, Bakker A, Cole S, Chorn N, Lin LS, Bristol G, Boyd MP, MacPherson JL, Fanning GC, Todd AV, Ely JA, Zack JA, Symonds GP: Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther. 2004, 15: 251-262. 10.1089\/104303404322886101.","journal-title":"Hum Gene Ther"},{"key":"2127_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nbt1367","volume":"25","author":"JJ Rossi","year":"2007","unstructured":"Rossi JJ, June CH, Kohn DB: Genetic therapies against HIV. Nat Biotechnol. 2007, 25: 1444-1454. 10.1038\/nbt1367.","journal-title":"Nat Biotechnol"},{"key":"2127_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/BF02458427","volume":"59","author":"O Lund","year":"1997","unstructured":"Lund O, Lund OS, Gram G, Nielsen SD, Schonning K, Nielsen JO, Hansen JE, Mosekilde E: Gene therapy of T helper cells in HIV infection: mathematical model of the criteria for clinical effect. Bull Math Biol. 1997, 59: 725-745. 10.1007\/BF02458427.","journal-title":"Bull Math Biol"},{"key":"2127_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jtbi.2005.05.005","volume":"238","author":"D von Laer","year":"2006","unstructured":"von Laer D, Hasselmann S, Hasselmann K: Impact of gene-modified T cells on HIV infection dynamics. Journal of theoretical biology. 2006, 238: 60-77. 10.1016\/j.jtbi.2005.05.005.","journal-title":"Journal of theoretical biology"},{"key":"2127_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/jgm.1401","volume":"11","author":"JM Murray","year":"2009","unstructured":"Murray JM, Fanning GC, Macpherson JL, Evans LA, Pond SM, Symonds GP: Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV. J Gene Med. 2009, 11: 1077-1086. 10.1002\/jgm.1401.","journal-title":"J Gene Med"},{"key":"2127_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nm.1932","volume":"15","author":"RT Mitsuyasu","year":"2009","unstructured":"Mitsuyasu RT, Merigan TC, Carr A, Zack JA, Winters MA, Workman C, Bloch M, Lalezari J, Becker S, Thornton L, Akil B, Khanlou H, Finlayson R, McFarlane R, Smith DE, Garsia R, Ma D, Law M, Murray JM, von Kalle C, Ely JA, Patino SM, Knop AE, Wong P, Todd AV, Haughton M, Fuery C, Macpherson JL, Symonds GP, Evans LA, Pond SM, Cooper DA: Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat Med. 2009, 15: 285-292. 10.1038\/nm.1932.","journal-title":"Nat Med"},{"key":"2127_CR22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1128\/JVI.79.3.1645-1654.2005","volume":"79","author":"JN Leonard","year":"2005","unstructured":"Leonard JN, Schaffer DV: Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. Journal of Virology. 2005, 79: 1645-1654. 10.1128\/JVI.79.3.1645-1654.2005.","journal-title":"Journal of Virology"},{"key":"2127_CR23","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","volume":"69","author":"LM Mansky","year":"1995","unstructured":"Mansky LM, Temin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 1995, 69: 5087-5094.","journal-title":"J Virol"},{"key":"2127_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature00896","volume":"418","author":"JM Jacque","year":"2002","unstructured":"Jacque JM, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature. 2002, 418: 435-438. 10.1038\/nature00896.","journal-title":"Nature"},{"key":"2127_CR25","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.4049\/jimmunol.169.9.5196","volume":"169","author":"J Capodici","year":"2002","unstructured":"Capodici J, Karik\u00f3 , Weissman D: Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol. 2002, 169: 5196-5201.","journal-title":"J Immunol"},{"key":"2127_CR26","doi-asserted-by":"publisher","first-page":"9225","DOI":"10.1128\/JVI.76.18.9225-9231.2002","volume":"76","author":"GA Coburn","year":"2002","unstructured":"Coburn GA, Cullen BR: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. Journal of Virology. 2002, 76: 9225-9231. 10.1128\/JVI.76.18.9225-9231.2002.","journal-title":"Journal of Virology"},{"key":"2127_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1128\/CMR.00017-07","volume":"20","author":"C Dykes","year":"2007","unstructured":"Dykes C, Demeter LM: Clinical significance of human immunodeficiency virus type 1 replication fitness. Clin Microbiol Rev. 2007, 20: 550-578. 10.1128\/CMR.00017-07.","journal-title":"Clin Microbiol Rev"},{"key":"2127_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1054-3589(07)56009-6","volume":"56","author":"ME Quinones-Mateu","year":"2008","unstructured":"Quinones-Mateu ME, Moore-Dudley DM, Jegede O, Weber J, E JA: Viral drug resistance and fitness. Adv Pharmacol. 2008, 56: 257-296. full_text.","journal-title":"Adv Pharmacol"},{"key":"2127_CR29","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1126\/science.1167525","volume":"323","author":"W Hubner","year":"2009","unstructured":"Hubner W, McNerney GP, Chen P, Dale BM, Gordon RE, Chuang FY, Li XD, Asmuth DM, Huser T, Chen BK: Quantitative 3 D video microscopy of HIV transfer across T cell virological synapses. Science. 2009, 323: 1743-1747. 10.1126\/science.1167525.","journal-title":"Science"},{"key":"2127_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/COH.0b013e328322f94a","volume":"4","author":"N Martin","year":"2009","unstructured":"Martin N, Sattentau Q: Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr Opin HIV AIDS. 2009, 4: 143-149. 10.1097\/COH.0b013e328322f94a.","journal-title":"Curr Opin HIV AIDS"},{"key":"2127_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.chom.2008.09.008","volume":"4","author":"JN Leonard","year":"2008","unstructured":"Leonard JN, Shah PS, Burnett JC, Schaffer DV: HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe. 2008, 4: 484-494. 10.1016\/j.chom.2008.09.008.","journal-title":"Cell Host Microbe"},{"key":"2127_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/gt.2008.124","volume":"16","author":"O ter Brake","year":"2009","unstructured":"ter Brake O, Legrand N, von Eije KJ, Centlivre M, Spits H, Weijer K, Blom B, Berkhout B: Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-\/-)gammac(-\/-)) mouse model. Gene Ther. 2009, 16: 148-153. 10.1038\/gt.2008.124.","journal-title":"Gene Ther"},{"key":"2127_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.virol.2007.10.045","volume":"372","author":"J Senserrich","year":"2008","unstructured":"Senserrich J, Pauls E, Armand-Ugon M, Clotet-Codina I, Moncunill G, Clotet B, Este JA: HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region. Virology. 2008, 372: 421-9. 10.1016\/j.virol.2007.10.045.","journal-title":"Virology"},{"key":"2127_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.mt.6300382","volume":"16","author":"OT ter Brake","year":"2008","unstructured":"ter Brake OT, Hooft KT, Liu YP, Centlivre M, Jasmijn von Eije K, Berkhout B: Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition. Mol Ther. 2008, 16: 557-64. 10.1038\/sj.mt.6300382.","journal-title":"Mol Ther"},{"key":"2127_CR35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/mt.2009.187","volume":"17","author":"JS Anderson","year":"2009","unstructured":"Anderson JS, Javien J, Nolta JA, Bauer G: Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy. Mol Ther. 2009, 17: 2103-2114. 10.1038\/mt.2009.187.","journal-title":"Mol Ther"},{"key":"2127_CR36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/387188a0","volume":"387","author":"AS Perelson","year":"1997","unstructured":"Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 1997, 387: 188-191. 10.1038\/387188a0.","journal-title":"Nature"},{"key":"2127_CR37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"D Finzi","year":"1999","unstructured":"Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF: Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999, 5: 512-517. 10.1038\/8394.","journal-title":"Nat Med"},{"key":"2127_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrm1644","volume":"6","author":"VN Kim","year":"2005","unstructured":"Kim VN: MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005, 6: 376-85. 10.1038\/nrm1644.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2127_CR39","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/nar\/30.8.1757","volume":"30","author":"T Holen","year":"2002","unstructured":"Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H: Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 2002, 30: 1757-1766. 10.1093\/nar\/30.8.1757.","journal-title":"Nucleic Acids Res"},{"key":"2127_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virusres.2004.01.015","volume":"102","author":"NS Lee","year":"2004","unstructured":"Lee NS, Rossi JJ: Control of HIV-1 replication by RNA interference. Virus Res. 2004, 102: 53-58. 10.1016\/j.virusres.2004.01.015.","journal-title":"Virus Res"},{"key":"2127_CR41","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.4049\/jimmunol.169.10.5754","volume":"169","author":"M McManus","year":"2002","unstructured":"McManus M, Haines BB, Dillon CP, Whitehurst CE, Van Parijs L, Chen J, Sharp PA: Small interfering RNA-mediated gene silencing in T lymphocytes. J Immunol. 2002, 169: 5754-5760.","journal-title":"J Immunol"},{"key":"2127_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1261\/rna.7233305","volume":"11","author":"R Yi","year":"2005","unstructured":"Yi R, Doehle BP, Qin Y, Macara IG, Cullen BR: Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA. 2005, 11: 220-226. 10.1261\/rna.7233305.","journal-title":"RNA"},{"key":"2127_CR43","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/nar\/gkn109","volume":"36","author":"YP Liu","year":"2008","unstructured":"Liu YP, Haasnoot J, Ter Brake O, Berkhout B, Konstantinova K: Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Research. 2008, 36: 2811-2824. 10.1093\/nar\/gkn109.","journal-title":"Nucleic Acids Research"},{"key":"2127_CR44","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/jgm.1080","volume":"9","author":"D Gou","year":"2007","unstructured":"Gou D, Weng T, Wang Y, Wang Z, Zhang H, Gao L, Chen Z, Wang P, Liu L: A novel approach for the construction of multiple shRNA expression vectors. J Gene Med. 2007, 9: 751-763. 10.1002\/jgm.1080.","journal-title":"J Gene Med"},{"key":"2127_CR45","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0960-9822(02)00975-2","volume":"12","author":"WY Hu","year":"2002","unstructured":"Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD: Inhibition of retroviral pathogenesis by RNA interference. Curr Biol. 2002, 12: 1301-1311. 10.1016\/S0960-9822(02)00975-2.","journal-title":"Curr Biol"},{"key":"2127_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.micinf.2003.10.009","volume":"6","author":"H Nishitsuji","year":"2004","unstructured":"Nishitsuji H, Ikeda T, Miyoshi H, Ohashi T, Kannagi M, Masuda T: Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes and Infection. 2004, 6: 76-85. 10.1016\/j.micinf.2003.10.009.","journal-title":"Microbes and Infection"},{"key":"2127_CR47","doi-asserted-by":"publisher","first-page":"12963","DOI":"10.1128\/JVI.76.24.12963-12973.2002","volume":"76","author":"RM Surabhi","year":"2002","unstructured":"Surabhi RM, Gaynor RB: RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication. J Virol. 2002, 76: 12963-12973. 10.1128\/JVI.76.24.12963-12973.2002.","journal-title":"J Virol"},{"key":"2127_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1742-4690-3-57","volume":"3","author":"E Westerhout","year":"2006","unstructured":"Westerhout E, ter Brake O, Berkhout B: The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology. 2006, 3: 57-10.1186\/1742-4690-3-57.","journal-title":"Retrovirology"},{"key":"2127_CR49","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1128\/JVI.78.2.568-575.2004","volume":"78","author":"M Egelhofer","year":"2004","unstructured":"Egelhofer M, Brandenburg G, Martinius H, Schult-Dietrich P, Melikyan G, Kunert R, Baum C, Choi I, Alexandrov A, von Laer D: Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J Virol. 2004, 78: 568-575. 10.1128\/JVI.78.2.568-575.2004.","journal-title":"J Virol"},{"key":"2127_CR50","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.gt.3302755","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Schiedlmeier B, Kuhlcke K, Verstegen M, Margison GP, Li Z, Kamino K, Bohne J, Alexandrov A, Hermann FG, von Laer D, Baum C: Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus. Gene Ther. 2006, 13: 1037-1047. 10.1038\/sj.gt.3302755.","journal-title":"Gene Ther"},{"key":"2127_CR51","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/mt.sj.6300124","volume":"15","author":"J van Lunzen","year":"2007","unstructured":"van Lunzen J, Glaunsinger T, Stahmer I, von Baehr V, Baum C, Schilz A, Kuehlcke K, Naundorf S, Martinius H, Hermann F, Giroglou T, Newrzela S, M\u00fcller I, Brauer F, Brandenburg G, Alexandrov A, von Laer D: Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. Mol Ther. 2007, 15: 1024-1033.","journal-title":"Mol Ther"},{"key":"2127_CR52","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","volume":"271","author":"AS Perelson","year":"1996","unstructured":"Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996, 271: 1582-1586. 10.1126\/science.271.5255.1582.","journal-title":"Science"},{"key":"2127_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1440-1711.2003.01191.x","volume":"81","author":"JM Murray","year":"2003","unstructured":"Murray JM, Kaufmann GR, Hodgkin PD, Lewin SR, Kelleher AD, Davenport MP, Zaunders JJ: Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Immunol Cell Biol. 2003, 81: 487-495. 10.1046\/j.1440-1711.2003.01191.x.","journal-title":"Immunol Cell Biol"},{"key":"2127_CR54","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF00219216","volume":"244","author":"B von Gaudecker","year":"1986","unstructured":"von Gaudecker B, Steinmann GG, Hansmann ML, Harpprecht J, Milicevic NM, Muller-Hermelink HK: Immunohistochemical characterization of the thymic microenvironment. A light-microscopic and ultrastructural immunocytochemical study. Cell Tissue Res. 1986, 244: 403-412.","journal-title":"Cell Tissue Res"},{"key":"2127_CR55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jgm.908","volume":"8","author":"D von Laer","year":"2006","unstructured":"von Laer D, Hasselmann S, Hasselmann K: Gene therapy for HIV infection: what does it need to make it work?. J Gene Med. 2006, 8: 658-667. 10.1002\/jgm.908.","journal-title":"J Gene Med"},{"key":"2127_CR56","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1128\/JVI.74.3.1234-1240.2000","volume":"74","author":"AE Jetzt","year":"2000","unstructured":"Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, Dougherty JP: High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol. 2000, 74: 1234-1240. 10.1128\/JVI.74.3.1234-1240.2000.","journal-title":"J Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-7-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-4690-7-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-7-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T19:04:37Z","timestamp":1591988677000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-7-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,9]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2127"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-7-83","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,9]]},"article-number":"83"}}